Oracle Investment Management as of Sept. 30, 2019
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 16 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 32.1 | $114M | 1.9M | 61.35 | |
| Accelr8 Technology | 27.4 | $98M | 5.2M | 18.57 | |
| Amarin Corporation (AMRN) | 22.0 | $78M | 5.2M | 15.16 | |
| Opko Health (OPK) | 3.4 | $12M | 5.8M | 2.09 | |
| Dermira | 3.3 | $12M | 1.8M | 6.39 | |
| Motus Gi Hldgs Incorporated | 2.1 | $7.5M | 3.8M | 1.98 | |
| Soleno Therapeutics | 1.6 | $5.8M | 3.9M | 1.50 | |
| Pacific Biosciences of California (PACB) | 1.6 | $5.7M | 1.1M | 5.16 | |
| Vermillion | 1.4 | $5.1M | 9.8M | 0.52 | |
| Biolase | 1.4 | $4.9M | 5.2M | 0.94 | |
| Agenus (AGEN) | 1.3 | $4.7M | 1.8M | 2.58 | |
| Biohaven Pharmaceutical Holding | 1.1 | $4.1M | 2.5M | 1.62 | |
| Contrafect | 0.5 | $1.6M | 4.4M | 0.36 | |
| Biogen Idec (BIIB) | 0.4 | $1.5M | 6.4k | 232.88 | |
| Antares Pharma | 0.3 | $963k | 288k | 3.34 | |
| SPDR S&P Biotech (XBI) | 0.0 | $50k | 250k | 0.20 |
